Back to GetFilings.com



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, DC   20549

     
     
 

FORM 10-Q

 
 
 

(MARK ONE) QUARTERLY REPORT /X/ OR TRANSITION REPORT /  /
             PURSUANT TO SECTION 13 OR 15 (d) OF
             THE SECURITIES EXCHANGE ACT OF 1934

     
     

For the quarter ended
July 31, 2003


Commission File No. 1-5865

   

Gerber Scientific, Inc.
(Exact name of Registrant as
specified in its charter)

Connecticut

06-0640743

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer
Identification No.)

83 Gerber Road West, South Windsor, Connecticut

06074

(Address of principal executive offices)

 

(Zip Code)

     

Registrant's Telephone Number, including area code

 

(860)644-1551

     
     

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

   

Yes /X/.      No /  /.

   

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).

Yes /X/.      No /  /.

 
 

At July 31, 2003, 22,188,356 shares of common stock of the Registrant were outstanding.


GERBER SCIENTIFIC, INC.
AND SUBSIDIARIES
CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

Quarter Ended July 31, 2003

 

   

Page

Part I - Financial Information

   
     
 

Item 1.

Consolidated Financial Statements (Unaudited):

 
         
   

Consolidated Statements of Operations for the three months
ended July 31, 2003 and 2002


2-3

         
   

Consolidated Balance Sheets at July 31, 2003 and
April 30, 2003


4-5

         
   

Consolidated Statements of Cash Flows for the three months
ended July 31, 2003 and 2002


6

         
   

Notes to Consolidated Financial Statements

7

         
   

Independent Accountants' Review Report

19

         
 

Item 2.

Management's Discussion and Analysis of
Financial Condition and Results of Operations


20

         
 

Item 3.

Quantitative and Qualitative Disclosures
About Market Risk


30

         
 

Item 4.

Controls and Procedures

32

         
         

Part II - Other Information

   
         
 

Item 2.

Changes in Securities and Use of Proceeds

33

         
 

Item 6.

Exhibits and Reports on Form 8-K

34

         
         

Signature

 

35

         

Exhibit Index

 

34


PART I -- FINANCIAL INFORMATION

ITEM 1.     CONSOLIDATED FINANCIAL STATEMENTS

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS


(Unaudited)

Three Months Ended
               July 31,                 

       

In thousands, except per share data

      2003 

 

      2002 

Revenue:

     

     Product sales

$114,689 

 

$112,227 

     Service sales

  14,268 

 

  13,651 

 

128,957 

 

125,878 

Costs and Expenses:

     

     Cost of products sold

77,635 

 

74,814 

     Cost of services sold

7,494 

 

7,192 

     Selling, general, and administrative

33,033 

 

31,713 

     Research and development

6,191 

 

6,276 

     Restructuring charges (Note 3)

       ---   

 

     (100)

 

124,353 

 

119,895 

Operating income

4,604 

 

5,983 

Other income (expense)

(1,016)

 

(866)

Interest expense

  (3,103)

 

  (2,231)

Earnings from continuing operations before income taxes

485 

 

2,886 

Provision for income taxes

      122 

 

      664 

Earnings from continuing operations

363 

 

2,222 

Discontinued operations (Note 9):

     

     Income from operations of disposed business, net of taxes of
         $92 in fiscal 2003


- ---   

 


172 

     Gain on sale of disposed business, net of taxes of $2,244
         in fiscal 2003


       ---   

 


   1,222 

Net earnings

$      363 

 

$  3,616 

 

======

 

======

 

Earnings per share of common stock:

     

Basic:

     

     Earnings from continuing operations

$        .02 

 

$       .10 

     Discontinued operations

       ---   

 

        .06 

     Net earnings

$        .02 

 

$       .16 

 

======

 

======

Diluted:

     

     Earnings from continuing operations

$        .02 

 

$       .10 

     Discontinued operations

       ---   

 

        .06 

     Net earnings

$        .02 

 

$       .16 

 

======

 

======

     Dividends

$       ---   

 

$      ---   

Average shares outstanding:

     

     Basic

22,173 

 

22,110 

     Diluted

22,473 

 

22,110 

See accompanying notes to consolidated financial statements.

2-3


GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

(Unaudited)


In thousands, except share data

July 31,
     2003     

 

April 30,
     2003     

Assets:

Current Assets:

     

     Cash and short-term cash investments

$   10,777 

 

$   20,697 

     Accounts receivable, net of allowance for doubtful
          accounts of $7,421 and $7,277, respectively


86,864 

 


89,657 

     Inventories

53,153 

 

51,982 

     Deferred income taxes

5,199 

 

5,300 

     Prepaid expenses and other current assets

      9,564 

 

      8,327 

 

  165,557 

 

  175,963 

Property, Plant and Equipment

120,768 

 

122,674 

     Less accumulated depreciation

    75,319 

 

    75,309 

 

    45,449 

 

    47,365 

Intangible Assets:

     

     Goodwill

49,160 

 

48,912 

     Prepaid pension cost

8,483 

 

8,483 

     Patents and other intangible assets, net of accumulated
        amortization


     6,773 

 


     6,777 

 

   64,416 

 

   64,172 

Deferred Income Taxes

14,965 

 

14,855 

Other Assets

     9,222 

 

     4,336 

 

$299,609 

 

$306,691 

 

=======

 

=======

Liabilities and Shareholders' Equity

     

Current Liabilities:

     

     Current maturities of long-term debt

$ 19,497 

 

$ 14,807 

     Accounts payable

38,919 

 

45,024 

     Accrued compensation and benefits

13,537 

 

23,167 

     Other accrued liabilities

20,411 

 

18,202 

     Deferred revenue

10,658 

 

10,000 

     Advances on sales contracts

    1,193 

 

        945 

 

104,215 

 

 112,145 

       

Noncurrent Liabilities:

     Accrued pension benefit liability

23,549 

 

23,549 

     Other liabilities

  5,451 

 

5,534 

     Long-term debt

  70,176 

 

  71,000 

 

  99,176 

 

 100,083 

 

Contingencies and Commitments (Note 10)

   

 

       

Shareholders' Equity:

     

     Preferred stock, no par value;
        authorized 10,000,000 shares; no shares issued


- --- 

 


- --- 

     Common stock, $1.00 par value;
        authorized 65,000,000 shares; issued
        22,926,033 and 22,908,180 shares, respectively



22,926 

 



22,908 

     Paid-in capital

43,696 

 

43,703 

     Retained earnings

68,275 

 

67,912 

     Treasury stock, at cost (737,677
        and 745,184 shares, respectively)


(15,169)

 


(15,323)

     Unamortized value of restricted stock grants

(195)

 

(211)

     Accumulated other comprehensive loss

  (23,315)

 

  (24,526)

 

   96,218 

 

   94,463 

 

$299,609 

 

$306,691 

 

=======

 

=======

See accompanying notes to consolidated financial statements.

4-5


GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS


(Unaudited)

Three Months Ended
                 July 31,                

       

In thousands

         2003 

 

         2002 

Cash Provided by (Used for):

     

Operating Activities:

     

     Net earnings

$     363 

 

$  3,616 

     Adjustments to reconcile net earnings
        to cash provided by (used for) operating activities:


 


          Depreciation and amortization

2,978 

 

3,390 

          Restructuring charges

--- 

 

(100)

          Gain on sale of disposed business, net of taxes

--- 

 

(1,222)

          Deferred income taxes

(214)

 

(152)

          Other non-cash items

917 

 

226 

     Changes in operating accounts:

     

          Receivables

1,975 

 

348 

          Inventories

(1,136)

 

(2,738)

          Prepaid expenses

(1,250)

 

3,871 

          Accounts payable and accrued liabilities

  (12,281)

 

  (2,656)

Provided by (Used for) Operating Activities:

    (8,648)

 

    4,583 

Investing Activities:

     

     Additions to property, plant, and equipment

(512)

 

(419)

     Intangible and other assets

(274)

 

(204)

     Proceeds from sales of assets

---  

 

2,506 

     Proceeds from sale of disposed business

         ---  

 

    6,595 

     Proceeds from settlement of promissory note

        994 

 

         --- 

Provided by Investing Activities:

        208 

 

    8,478 

Financing Activities:

     

     Additions of long-term debt

 107,704

 

3,000 

     Repayments of long-term debt

(103,838)

 

(10,222)

     Debt issue costs

(5,604)

 

(376)

     Exercise of stock options

34 

 

--- 

     Other common stock activity

51 

 

(8)

     Net short-term financing

         --- 

 

       353 

(Used for) Financing Activities:

  (1,653)

 

  (7,253)

Effect of exchange rate changes on cash

173 

 

597 

Increase (Decrease) in Cash and Short-Term Cash      Investments


(9,920)

 


6,405 

Cash and Short-Term Cash Investments, Beginning of Period

 20,697 

 

 16,220 

Cash and Short-Term Cash Investments, End of Period

$ 10,777 

 

$22,625 

======

======

See accompanying notes to consolidated financial statements.

6


GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1.   Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended July 31, 2003 are not necessarily indicative of the results that may be expected for the year ended April 30, 2004. The financial information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and notes in the Company's annual report on Form 10-K for the f iscal year ended April 30, 2003, filed with the SEC on July 29, 2003. The balance sheet at April 30, 2003 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

NOTE 2.   Inventories

The classification of inventories was as follows (in thousands):

 

July 31, 2003

April 30, 2003

Raw materials & purchased parts

$29,464

$28,796

Work in process

1,826

1,859

Finished goods

  21,863

  21,327

 

$53,153

$51,982

 

======

======

NOTE 3.   Restructuring

In fiscal 2003 and fiscal 2002, the Company recorded restructuring charges, consisting of employee separation and facility consolidation costs, associated with ongoing efforts to reduce costs. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended April 30, 2003 filed with the SEC on July 29, 2003.

FY2003 Restructuring Update

The following table displays a roll forward of the accrual established in fiscal 2003 by segment (in thousands):

7


 

Employee
Severance
  Accrual  

Facility
Consolidation
  Accrual  



       Total  

Sign Making and Specialty Graphics

     

Balance at April 30, 2003

$     666 

$       --- 

$    666 

Utilization

    (227)

        --- 

    (227)

Ending balance at July 31, 2003

439 

--- 

439 

       

Apparel and Flexible Materials

     

Balance at April 30, 2003

602 

401 

1,003 

Utilization

    (401)

      (45)

    (446)

Ending balance at July 31, 2003

      201 

     356 

     557 

       
 

$     640 

$    356 

$    996 

 

======

======

======

Of the remaining balance at July 31, 2003, $0.8 million is expected to be paid in fiscal 2004, $0.1 million in fiscal 2005, and $0.1 million in fiscal 2006.

FY 2002 Restructuring Update

As of April 30, 2003, accruals of approximately $1.0 million for severance costs remained, all of which represented severance and other amounts payable to the former Chief Executive Officer. In the three months ended July 31, 2003, approximately $0.5 million in cash payments were charged against this accrual, reducing the balance to $0.5 million at July 31, 2003. Of this remaining balance, $0.2 million is expected to be paid in fiscal 2004 and $0.3 million is expected to be paid in fiscal 2005.

NOTE 4.   Goodwill and Other Intangible Assets

Goodwill and other intangible assets include (in thousands):

 

         As of July 31, 2003       

        As of April 30, 2003      

 

Gross Carrying
Amount

 


Accumulated
Amortization

Gross Carrying
Amount

 


Accumulated
Amortization

Amortized intangible assets:

           

  Patents

$ 10,514

 

$ 4,108

$ 10,300

 

$ 3,886

  Other

    1,118

 

     751

    1,073

 

     710

 

11,632

 

4,859

11,373

 

4,596

Unamortized intangible assets:

           

  Goodwill

49,160

 

---

48,912

 

---

  Prepaid pension cost

    8,483

 

       ---

    8,483

 

       ---

 

  57,643

 

       ---

  57,395

 

       ---

 

$ 69,275

 

$ 4,859

$ 68,768

 

$ 4,596

 

======

 

=====

======

 

=====

8


Intangible amortization expense was $0.3 million and $0.4 million for the three months ended July 31, 2003 and 2002, respectively, and is estimated to be approximately $0.8 million in fiscal 2004, approximately $0.6 million for fiscal year 2005, and approximately $0.5 million annually for fiscal years 2006-2009.

The following table displays the changes in the carrying amount of goodwill by operating segment for the quarter ended July 31, 2003 (in thousands):

 

Sign Making
& Specialty
Graphics

Apparel
& Flexible
Materials

Ophthalmic
Lens
Processing



Total

Balance as of May 1, 2003

$ 19,276

$ 12,640

$ 16,996 

$ 48,912 

Effects of currency translation

       243

         5

        --- 

      248 

Balance as of July 31, 2003

$ 19,519

$ 12,645

$ 16,996 

$ 49,160 

 

======

======

======

======

NOTE 5.   Derivative Instruments and Hedging Activities

The Company is exposed to fluctuations in foreign currency exchange rates. To manage these risks, the Company uses forward exchange contracts. Derivative instruments used in hedging activities are viewed as risk management tools, involve little complexity, and are not used for trading or speculative purposes. Counterparties to forward exchange contracts were major international commercial banks. The Company continually monitors its open forward exchange contract position and does not anticipate non-performance by the counterparties.

Foreign Currency Risk

The Company's global presence and international sales and purchases expose it to fluctuations in foreign currency exchange rates. Foreign currency exposures are identified and managed at the operating unit level. The Company has foreign currency forward contracts that are designated and effective as a hedge of the cash flow variability arising from forecasted foreign-currency denominated sales and purchases. Accordingly, changes in the fair value of these contracts must be highly correlated with changes in the fair value of the underlying hedged item at inception of the hedge and over the life of the hedge contract. Gains and losses on these derivatives are recorded in shareholders' equity to the extent they are effective as hedges and reclassified into earnings in the period in which the hedged transaction impacts earnings. There were no gains and losses recognized in earnings related to the ineffectiveness of cash flow hedges during the three months ended July 31, 2003.

As of July 31, 2003, the Company was party to approximately $24.6 million in forward exchange contracts providing for the delivery of the various currencies in exchange for others over the succeeding 12 months. The fair value of the contracts outstanding at July 31, 2003 was a $1.8 million net liability.

Year to Date Activity

The changes in shareholders' equity associated with hedging activity for the three months ended July 31, 2003 and 2002 were as follows:

9



  Three Months Ended
                 July 31,            

In thousands

     2003

    2002

Balance -- May 1, 2003 and 2002

$ (1,420)

$    (669)

Cash flow hedging loss

(328)

(1,609)

Net loss reclassified to income statement

      660 

      534 

Balance -- July 31, 2003 and 2002

$ (1,088)

$ (1,744)

 

======

======

Of the amount recorded in shareholders' equity at July 31, 2003, a $1.1 million loss is expected to be reclassified into earnings in fiscal 2004.

NOTE 6.   Segment Information

The Company's operations are classified into three operating segments: Sign Making and Specialty Graphics; Apparel and Flexible Materials; and Ophthalmic Lens Processing. Those segments are determined based on management's evaluation of the Company's businesses. Financial data for the three months ended July 31, 2003 and 2002 are shown in the following tables.

 

Three Months Ended
             July 31,            

 

In thousands

    2003   

    2002   

   

Segment revenue:

       

    Sign Making & Specialty Graphics

$  72,841  

$  66,394

   

    Apparel & Flexible Materials

37,607  

38,678

   

    Ophthalmic Lens Processing

  18,509  

   20,806

   

$128,957  

$125,878

 

======  

======

   

Segment profit (loss):

       

    Sign Making & Specialty Graphics

$    5,069  

$    4,489

   

    Apparel & Flexible Materials

2,973  

3,994

   

    Ophthalmic Lens Processing

       (41)  

     1,081

   
 

$    8,001  

$    9,564

   
 

======  

======

   

A reconciliation of total segment profit to consolidated income from continuing operations before income taxes follows:

 

Three Months Ended
             July 31,            

 

In thousands

     2003    

    2002    

   

Segment profit

$   8,001 

$    9,564 

   

Corporate expenses, net of other income

 (4,413)

 (4,447)

   

Earnings before interest and taxes

3,588 

5,117 

   

Interest expense

 (3,103)

 (2,231)

   

Earnings from continuing operations
   before income taxes


$      485 


$   2,886 

   

======

======

10


Segment profit for the three months ended July 31, 2002 included reversals of previously established restructuring reserves of $0.1 million for the Apparel and Flexible Material operating segment.

There were no material changes in segment assets, the measure of segment profit, or differences in the basis of segmentation since the Company's last Annual Report on Form 10-K filed on July 29, 2003.

NOTE 7.   Comprehensive Income

The Company's total comprehensive income was as follows:

 

Three Months Ended
               July 31,           

In thousands

    2003 

    2002 

Net earnings

$    363 

$ 3,616 

Other comprehensive income (loss):

   

    Foreign currency translation adjustments

879 

5,961 

    Cash flow hedging gain (loss), net

   332 

(1,075)

    Total comprehensive income

$ 1,574 

$ 8,502 

 

=====

===== 

NOTE 8.   Earnings Per Share

The following table sets forth the computation of basic and diluted net earnings per common share:

 

Three Months Ended
               July 31,           

In thousands, except per share amounts

    2003 

    2002 

Numerator:

   

Earnings from continuing operations

$   363 

$ 2,222

Discontinued operations:

   

   Income from operations of disposed       business, net of tax


- ---  


172

   Gain on sale of disposed business, net of       tax


       ---  


  1,222

   Net earnings

$      363 

$ 3,616

 

======

=====

Denominators:

   

   Denominator for basic earnings per       share -- weighted-average shares       outstanding



22,173 



22,110 

   Effect of dilutive securities:

   

   Stock options

      300 

       ---  

   Denominator for diluted earnings per
      share--adjusted weighted-average
      shares outstanding



22,473 



22,110 

 

======

======

Basic earnings per share from
   continuing operations


$        .02 


$      .10

Discontinued operations

        ---  

       .06

Basic earnings per share

$        .02 

$      .16

 

======

=====

Diluted earnings per share from
   continuing operations


$        .02 


$      .10

Discontinued operations

        ---  

       .06

Diluted earnings per share

$        .02 

$      .16

 

======

=====

For the three month periods ended July 31, 2003 and 2002, 2.4 million and 4.4 million, respectively, of common stock equivalents were antidilutive and not included in the above calculation.

11


NOTE 9.   Discontinued Operations

On July 1, 2002, the Company completed the sale of Stereo Optical Company, Inc. (Stereo Optical), which was included in the Ophthalmic Lens Processing operating segment, for $7.5 million in cash less an amount held in escrow for purchase price adjustments, the majority of which has been collected. Stereo Optical was accounted for as a discontinued operation beginning with the fiscal 2003 consolidated financial statements. This accounting recognition was required by the Company's adoption of Statement of Financial Accounting Standards No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." The gain on disposition was $3.5 million before income taxes and $1.2 million after taxes, or $.06 per diluted share. Stereo Optical's revenue and pre-tax income reported in discontinued operations were $0.7 million and $0.3 million, respectively, for the three-month period ended July 31, 2002.

NOTE 10.   Commitments and Contingencies

There were no significant changes to the commitments and contingencies during fiscal 2004. Summarized below, however, are the matters previously disclosed in Note 17 of the "Notes to Consolidated Financial Statements" in the Company's Annual Report on Form 10-K filed on July 29, 2003.

SEC Enforcement Investigation

In September 2000, the Division of Enforcement of the Securities and Exchange Commission initiated an investigation relating to possible insider trading activity with respect to the Company's securities. In October 2001, the SEC expanded its investigation to encompass the Company's inventory and reserve accounting practices and related disclosures. The Enforcement staff has since asked for information and documents relating to various accounting and other matters (including matters that have been addressed through the restatement of our prior annual financial statements for fiscal years 2001 and 2002). In addition, the staff has taken the testimony of current and former officers and employees of the Company. The Company believes that it has cooperated fully with the staff during the course of this investigation. If the SEC's investigation results in any formal adverse findings, the Company's financial condition, results of operations, and business could be adversely affected. The Company has incurred, and expects to continue to incur, significant legal and other costs in connection with this investigation. As the investigation is ongoing, the Company cannot predict the length nor the potential outcome of the investigation, nor the potential impact on the Company.

12


Claims Which May Be Asserted Under the Company's 401(k) Plan

In December 1997, the Company registered 350,000 shares of the Company's common stock to be purchased by an independent trustee in the open market for the benefit and at the direction of Company employees pursuant to the Gerber Scientific, Inc. and participating Subsidiaries 401(k) Maximum Advantage Program and Trust (the "Plan"). Approximately 1,100,000 shares were acquired by Plan participants before this option was discontinued on July 15, 2002.

The purchase of shares under the Plan in excess of the number of shares registered may have been exempt from registration under the Securities Act of 1933. The Company understands, however, that the staff of the Securities and Exchange Commission takes the position that one possible exemption, under Section 3(a)(2) of the Securities Act, would not apply to shares of an employer-sponsored plan acquired in the open market by an independent trustee at the direction and for the benefit of employee participants pursuant to plans of this type (i.e., plans in which employee contributions can be directed toward the purchase of a company's stock and the company's matching contributions may be less than 1-for-1).

If the acquisitions of these shares are found not to have been exempt from registration, the Company could be liable under Section 12(a)(1) of the Securities Act for rescission or damages to the employees who purchased these shares. Under Section 13 of the Securities Act, a rescission right, which is the effective equivalent to a "put" right, can be maintained to enforce liability under Section 12(a)(1) at any time within one year after the violation on which it is based but not more than three years after the relevant securities were first offered to the public. A rescission right would entitle the employee purchasers of these shares to receive the return of the amounts paid for these shares, together with interest from the date of purchase.

The current members of the Plan's administrative committee, on the advice of counsel, requested the Company to toll (effective July 25, 2002), any statutes of limitations with respect to claims which might be made by or on behalf of Plan participants alleging that the Company should have registered these shares. The Company acceded to this request and entered into a tolling agreement, which has been extended, most recently to September 25, 2003, to allow the independent fiduciary described below adequate time to study the issue. The prices paid for shares acquired during the one year prior to July 25, 2002 aggregated approximately $2,100,000.  The prices paid for all of the unregistered shares which were acquired under the Plan aggregated approximately $7,300,000. In July 2003, the Company appointed an independent fiduciary under the Plan to deal with all matters on behalf of the Plan related to the facts described above.

13


In addition to any claims that may be asserted under the Securities Act, claims may also be asserted under the Employee Retirement Income Security Act of 1974 for recovery of losses incurred with respect to the purchase of the unregistered shares.

The Company does not currently intend to offer rescission to the purchasers of these shares and intends to defend against any claim for either rescission or damages. However, the possibility of such a claim gives rise to a contingent liability that, if realized, could adversely affect the financial condition of the Company. Given the current status of this unasserted claim, the Company cannot reasonably estimate a loss.

Other

We currently have lawsuits, as well as claims and government proceedings, pending against us. Our management believes that the ultimate resolution of these other lawsuits, claims, and proceedings will not have a material effect on our consolidated financial condition, results of operations, liquidity, or competitive position.

NOTE 11.   Guarantees

In December 2002, the Company adopted Financial Accounting Standards Board Interpretation No. 45 ("FIN 45"), "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others." FIN 45 requires that a liability be recorded in the guarantor's balance sheet upon issuance of a guarantee. FIN 45 also requires disclosures by a guarantor in its interim and annual financial statements about the obligations associated with guarantees issued, including a roll forward of product warranty liabilities. The initial recognition and measurement provisions of FIN 45 were effective for any guarantees that met certain criteria under FIN 45 that were issued or modified after December 31, 2002. Adoption of the initial recognition and measurement provisions of FIN 45 did not materially impact our financial position or results of operations. The Company adopted the disclosure requirements of FIN 45 as of January 31, 2003.

The Company extends financial and product performance guarantees to third parties. There have been no material changes to guarantees outstanding since April 30, 2003.

The changes in the carrying amount of product warranties for the three months ended July 31, 2003, are as follows:

In thousands

 

Beginning balance, May 1, 2003

$  4,372 

Reductions for payments made

(1,374)

Changes in accruals related to warranties issued
     in the current period


 1,277 

Ending balance, July 31, 2003

$ 4,275 

 

=====

NOTE 12.   Stock Option Plans

The Company has stock option plans authorizing grants to officers and employees. The Company applies APB Opinion No. 25, "Accounting for Stock Issued to Employees," and related interpretations in accounting for its stock options. No stock-based compensation cost related to stock options is reflected in net earnings because all options granted under these plans had an exercise price equal to the market value of the underlying common stock on the date of the grant.

14


The following table illustrates the effect on net earnings and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, "Accounting for Stock-Based Compensation" (SFAS No. 123):

 

Three Months Ended
               July 31,            

In thousands, except per share amounts

         2003

      2002

     

Net earnings, as reported

$    363 

$ 3,616 

Less: Total stock-based employee compensation
          expense determined under Black-Scholes
          option pricing model, net of tax effects



 (335)



  (761)

Pro forma net earnings

$     28 

$ 2,855 

 

====

=====

Net earnings per share

   

     Basic, as reported

$    .02 

$     .16 

     Basic, pro forma

 .00 

.13 

     

     Diluted, as reported

$    .02 

$     .16 

     Diluted, pro forma

 .00 

.13 

NOTE 13.   Long-Term Debt

On May 9, 2003, the Company entered into a four-year $110.0 million senior credit facility arranged by Fleet Securities, Inc. The financing consisted of a $45.0 million asset-based, multi-currency revolving credit facility (the "Revolver") led by Fleet Capital Corporation, and two term loan facilities, each in the amount of $32.5 million (the "Term A Loan" and "Term B Loan" and collectively, the "Term Loans") (the Revolver and Term Loans being collectively referred to as the "Credit Facilities") led by Ableco Finance LLC, a fund affiliated with Cerberus Capital Management, L.P.

The lenders under these arrangements have been granted security interests in selected assets of the Company and its subsidiaries including certain real estate and leasehold interests in the U.S. and elsewhere; inventory and accounts receivable in the U.S., Canada, U.K., Germany, and the Netherlands; intangible assets; intellectual property; and other assets.

The initial borrowings under the Credit Facilities have been or will be used:

15


Revolver

Under the Revolver, there are no required principal payments prior to maturity, though the amount of the revolving credit commitment is subject to reduction. Commitment reductions or termination, at the Company's option, under the Revolver are permitted at any time without fee, except in the case of commitment reductions or termination before May 9, 2004, for which a fee in the amount of 1 percent is required.

Borrowings are subject to a borrowing base formula based upon eligible accounts receivable and inventories. Obligations under the Revolver bear interest at a floating rate, which is, at the Company's option, either a base rate or LIBOR, in each case plus an applicable margin. The base rate is Fleet National Bank's base rate. The initial applicable margin for borrowings under the Revolver is 1.25 percent over the base rate and 2.75 percent over LIBOR. After October 31, 2003, the applicable margins under the Revolver are subject to adjustment based on the relationship between the Company's total funded debt to EBITDA, defined as earnings before interest, taxes, depreciation, and amortization.

Under the Revolver, the Company is required to pay a commitment fee on the difference between the total committed amount of the facility and the amount borrowed by the Company. The initial commitment fee is 0.50 percent per year. The commitment fee is subject to adjustment based on the relationship of the Company's total funded debt to EBITDA.

The Company is required to maintain certain financial covenants set forth in the agreement including certain fixed charge coverage ratios, total liabilities to tangible capital base ratios, and consolidated EBITDA, as well as limitations on capital expenditures. The agreement also includes limitations on additional indebtedness and liens, contingent liabilities, asset sales and dividends, investments and hedging activities, transactions with affiliates, legal entity changes, and other customary covenants and representations. At July 31, 2003 the Company was in compliance with these covenants.

The Revolver agreement requires the Company to maintain a lock-box arrangement with Fleet National Bank whereby amounts received into the lock-boxes are applied to reduce the Revolver debt outstanding. The Revolver agreement also contains certain subjective acceleration clauses in the event of a material adverse event. EITF 95-22, "Balance Sheet Classification of Borrowings Outstanding under Revolving Credit Agreements That Include both a Subjective Acceleration Clause and a Lock-Box Arrangement" requires the Company to classify outstanding borrowings under the Revolver as short-term obligations due to the existence of both a lock-box arrangement and subjective acceleration clauses.

Term Loans

Voluntary prepayments of principal under the Term Loans are permitted at any time without penalty or premium. Subject to certain exceptions, mandatory principal prepayments under the Term Loans are required with cash proceeds of debt issuances, asset sales, casualty events, and excess cash flow.

16


Obligations under the Term Loans bear interest at a floating rate of 6 percent over prime rate for Term A Loan borrowings and 7.5 percent over prime rate for Term B Loan borrowings. The prime rate is JP MorganChase Bank's prime rate, except at no time will the prime rate be lower than 4.25 percent or higher than 7.25 percent. The Term Loans also accrue interest that can either be added to the loan principal ("PIK") or paid in cash of 2 percent per year. In addition, an annual fee amounting to 1.75 percent of the average monthly balance of the Term Loans is required to be paid on each anniversary of the loan closing date. The PIK interest rate and the anniversary fee are subject to 1 percent and 0.50 percent reductions, respectively, when certain EBITDA levels are achieved.

The Company is required to maintain certain financial covenants as set forth in the agreement including certain leverage ratios, fixed charge coverage ratios, and consolidated EBITDA levels, as well as limitations on capital expenditures. The agreement also includes limitations on additional indebtedness and liens, contingent liabilities, asset sales, dividends, issuance of capital stock, investments and hedging activities, transactions with affiliates, legal entity changes, and other customary covenants and representations. At July 31, 2003 the Company was in compliance with these covenants.

17


GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

With respect to the unaudited consolidated financial statements of Gerber Scientific, Inc. and subsidiaries at July 31, 2003 and for the three-month periods ended July 31, 2003 and 2002, KPMG LLP has made a review (based on procedures adopted by the American Institute of Certified Public Accountants) and not an audit, as set forth in their separate report dated August 27, 2003 appearing on Page 19. That report does not express an opinion on the interim unaudited consolidated financial information. KPMG LLP has not carried out any significant or additional audit tests beyond those which would have been necessary if their report had not been included. Accordingly, such report is not a "report" or "part of the Registration Statement" within the meaning of Sections 7 and 11 of the Securities Act of 1933 and the liability provisions of Section 11 of such Act do not apply.

18


INDEPENDENT ACCOUNTANTS' REVIEW REPORT

 

To the Board of Directors and Shareholders of
Gerber Scientific, Inc.:

 

We have reviewed the accompanying consolidated balance sheet of Gerber Scientific, Inc. and subsidiaries as of July 31, 2003, and the related consolidated statements of operations and cash flows for the three-month periods ended July 31, 2003 and 2002. These consolidated financial statements are the responsibility of the Company's management.

We conducted our review in accordance with standards established by the American Institute of Certified Public Accountants. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with auditing standards generally accepted in the United States of America, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the consolidated financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with auditing standards generally accepted in the United States of America, the consolidated balance sheet of Gerber Scientific, Inc. and subsidiaries as of April 30, 2003, and the related consolidated statements of operations, changes in shareholders' equity, and cash flows for the year then ended (not presented herein); and in our report dated May 28, 2003, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of April 30, 2003, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

 

/s/ KPMG LLP

Hartford, Connecticut
August 27, 2003

19


ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                    CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

Demand for our capital equipment products continued to be soft in the first quarter of fiscal 2004. Adjusting for the favorable effects of foreign currency translation, each of our operating segments reported lower revenues than the prior year comparable period. Weak global economic conditions affected retail level consumer spending on products manufactured by our equipment and caused our customers to curtail capital spending. Sales of our aftermarket products were higher in the first quarter of fiscal 2004 compared to the same period last year, which partially offset the effect of the lower capital equipment demand and provided stability during this difficult business environment.

Equipment and aftermarket supplies and service revenues as a percentage of total revenues during the first quarter of fiscal 2004 compared to the same period of 2003 are reflected in the table below:

 

Three months ended

 

July 31, 2003

July 31, 2002

     

Equipment revenue

30%

34%

Aftermarket supplies & service revenue

70%

66%

Our gross margin was lower in the first quarter of fiscal 2004 compared to the same period last year due primarily to the lower volume of business, higher levels of price discounting, and a higher proportion of lower margin product sales this year compared to last year. Cost savings resulting from reductions implemented in last year's third quarter somewhat offset these factors.

We also incurred higher pension and interest expense in the first quarter of fiscal 2004 compared to the same period last year, which further reduced earnings. Lower incentive compensation expense and legal and professional expense associated with the Securities and Exchange Commission's ("SEC's") continuing investigation were significant offsets.

In the first quarter of fiscal 2004, we refinanced our multi-currency revolving credit facility with a four-year $110.0 million senior credit facility consisting of a $45.0 million asset-based revolving credit facility and two term loan facilities, each in the amount of $32.5 million. We previously disclosed the terms of the senior credit facility.

Our focus continues to be the execution of our stated turnaround plan. This includes continuing the implementation of the shared services initiative, improving the operations of the Sign Making and Specialty Graphics segment's European distribution business, and new product innovation to improve operating results.

The Ophthalmic Lens Processing segment's operations will be merged into the shared services initiative during fiscal 2004. Through this initiative, certain operations of the Apparel and Flexible Materials segment's and the Sign Making and Specialty Graphics segment's U.S. businesses have already been combined. The shared services initiative encompasses strategic purchasing, inventory management, freight and logistics costs, as well as factory integration, ERP system consolidations, and facility consolidations.

20


We will also continue to consolidate warehouses and implement the Company's enterprise resources planning system (ERP) throughout the Sign Making and Specialty Graphics segment's European businesses during fiscal 2004. To date, this segment's France and Germany warehouses have been combined and the ERP system was implemented in four countries.

The fiscal 2004 shared services and warehouse consolidation programs will result in additional restructuring charges. We cannot yet estimate the effect of these charges on our operating results, as the programs are still being refined.

There is no guarantee that the above described components of our turnaround plan will yield the results management expects. There are risks involved with implementing the shared services initiative, consolidating warehouses, and developing new products. These measures may raise product costs, delay product production and service delivery, result in strained relations with our employees or customers, or create inefficiencies in the business. Further, they could give rise to unforeseen costs which could wholly, or partially, offset any expected expense reductions or other financial benefits.

We do not anticipate meaningful improvement in the current economic outlook and demand for our capital equipment products throughout fiscal 2004. Given this expectation, our cost reduction initiatives are of critical importance.

RESULTS OF OPERATIONS

Revenues. Consolidated revenues were $129.0 million in the first quarter of fiscal 2004, an increase of $3.1 million (2.4 percent), when compared to the same period of fiscal 2003. Foreign currency translation contributed approximately $10.1 million of the revenue increase in the quarter ended July 31, 2003 due primarily to the strengthening of the Euro and Pound Sterling in relation to the U.S. dollar. Adjusting for the foreign currency translation effect, capital equipment revenue declines occurred in each of our operating segments. This was partially offset by steady levels of aftermarket supplies and service revenue in each of our operating segments.

On a geographic basis, our volume of business in the first quarter of fiscal 2004 compared to the same period last year was higher in European and Rest of World regions and substantially offset by declines in the U.S. The decrease in U.S. revenues was primarily the result of lower capital equipment shipments in the Ophthalmic Lens Processing and Apparel and Flexible Materials segments. The Ophthalmic Lens Processing segment decline was caused by the absence of incremental equipment shipments to U.S. retail and discount eyewear chains that occurred in the first quarter of fiscal 2003, which were not expected to be repeated in fiscal 2004. Apparel and furniture production migration to emerging markets caused the U.S. region decline in the Apparel and Flexible Materials segment, which also caused the majority of overall revenue growth in Rest of World regions. The European region benefited from the favorable foreign currency translation. However, weak European market and industry conditi ons were significant offsets, particularly in the Apparel and Flexible Materials operating segment.

21


Gross Profit Margins. Gross margin as a percentage of sales decreased 0.9 percentage points in the first quarter to 34.0 percent compared to the same period last year. Gross margins on product sales decreased in the first quarter of 2004 and on service revenue were roughly the same compared to the same period last year. Decreases in the product gross profit margin were the result of pricing pressures, the effects of lower sales volume, and an unfavorable sales mix favoring lower margin aftermarket and equipment products over higher margin software products. Additionally, a higher proportion of Apparel and Flexible Materials segment sales were made through third-party agents, as opposed to the segment's internal sales force, which also lowered margins.

Selling, General, & Administrative Expenses. Selling, general and administrative (S,G&A) expenses increased $1.3 million (4.2 percent) in the first quarter of fiscal 2004 when compared to the same period of 2003. As a percentage of sales, S,G&A expenses were 25.6 percent in the first quarter of fiscal 2004 compared to 25.2 percent of revenue for the same period of 2003. The first quarter increase was primarily due to higher pension and other retirement costs and the impact of foreign currency translation in the Sign Making and Specialty Graphics and Apparel and Flexible Materials segments. These increases were partially offset by lower fiscal 2004 first quarter legal and professional expenses related to the ongoing SEC investigation and lower incentive compensation expense.

Research and Development. Research and development (R&D) expenses of $6.2 million were essentially the same in the first quarter of fiscal 2004 compared to the same period of 2003. As a percentage of sales, R&D expenses were 4.8 percent in the first quarter of fiscal 2004 compared to 5.0 percent for the same period of 2003. The steady level of R&D spending reflects our continuing commitment to new product development.

Other Income (Expense). The first quarter of fiscal 2004 included losses of approximately $0.4 million caused by translating foreign currency denominated transactions compared to losses of $0.9 million for the same period of 2003. Also included in the first quarter of fiscal 2004 was a loss of approximately $0.3 million caused by the write-off of deferred debt issuance costs related to the previous multi-currency credit facility that was in place through May 9, 2003.

Interest Expense. Interest expense increased $0.9 million (39.1 percent) in the first quarter of fiscal 2004 to $3.1 million when compared to the same period of 2003. The increase was the result of higher interest rates associated with the senior credit facilities entered into on May 9, 2003, which was partially offset by lower weighted average debt balances during the first quarter of fiscal 2004.

Income Tax Expense. The effective rate for taxes on income from continuing operations in the first quarter of fiscal 2004 was 25.2 percent compared to 23.0 percent for the same period last year. The difference between this year's tax rate and the U.S. statutory rate of 35.0 percent was primarily attributed to benefits related to tax planning strategies involving our businesses outside the U.S.

22


Discontinued Operations. On July 1, 2002, we completed the sale of Stereo Optical Company, Inc. (Stereo Optical), which was included in the Ophthalmic Lens Processing operating segment, for $7.5 million in cash less an amount held in escrow for purchase price adjustments. The majority of the cash proceeds have been collected. Stereo Optical was accounted for as a discontinued operation beginning with the fiscal 2003 consolidated financial statements. This accounting recognition was required by our adoption of Statement of Financial Accounting Standards No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." The gain on disposition was $3.5 million before taxes and $1.2 million after taxes, or $.06 per diluted share. Stereo Optical's revenue and pre-tax income reported in discontinued operations were $0.7 million and $0.3 million, respectively, for the three-month period ended July 31, 2002.

Net earnings. As a result of the above, net earnings in the first quarter of fiscal 2004 were $0.4 million, or $.02 per diluted share, compared to $3.6 million, or $.16 per diluted share, for the same period of 2003.

Restructuring Charges. During fiscal 2003, we recorded pre-tax restructuring charges of $1.4 million associated with the implementation of our shared services initiative between Gerber Technology and Gerber Scientific Products. Additionally, charges of $0.5 million were recorded as restructuring costs to consolidate Spandex warehouses in France and Germany. Charges associated with operating segments were: Apparel and Flexible Materials, $1.2 million and Sign Making and Specialty Graphics, $0.7 million. During fiscal 2004, we incurred cash outflows relating to the fiscal 2003 actions of $0.7 million, which were funded by cash generated from operations. As of July 31, 2003, the fiscal 2003 program was completed; however, cash payments will continue through fiscal 2006.

During fiscal 2002, we recorded pre-tax restructuring charges of $5.0 million associated with ongoing efforts to reduce costs. Charges associated with operating segments and corporate headquarters were: Apparel and Flexible Materials, $1.5 million; Sign Making and Specialty Graphics, $1.0 million, Ophthalmic Lens Processing, $0.3 million, and general corporate, $2.2 million. The corporate level charges, as well as those of certain operating segments, were coincident with a decision to pursue a corporate shared services model for our operating units. In the current fiscal year, we incurred cash outflows related to the fiscal 2002 program of $0.5 million, which were funded by cash generated from operations. As of July 31, 2003, the fiscal 2002 program was complete; however, cash payments will continue into fiscal 2005.

In the fiscal 2003 first quarter, we reversed previously established restructuring reserves totaling $0.1 million before taxes. The reversal of these reserves was recorded in the Consolidated Statement of Operations as restructuring charges, which is where the reserves were originally recorded. See Note 3 of the "Notes to Consolidated Financial Statements" contained in this Quarterly Report and our fiscal 2003 Form 10-K filed on July 29, 2003 for further discussion of the restructuring charges recorded in previous fiscal years.

Segment Review

Sign Making and Specialty Graphics segment revenues increased $6.4 million (9.7 percent) in the first quarter of fiscal 2004 compared to the same period last year. The favorable impact of foreign currency translation contributed approximately $7.8 million to the revenue increase reflecting the strengthening of the Euro and Pound Sterling in relation to the U.S. dollar. Holding foreign currency translation constant with last year's first quarter rates, revenue decreases occurred in each geographic region except for in the U.S., where revenue was slightly higher than in the prior year. In addition to lower demand for segment capital equipment products, particularly in Europe, revenues were lower in France due to management focus on the consolidation of that country's warehouse. Despite this short-term effect, this warehouse consolidation, as well as future consolidations, is expected to improve segment profit throughout fiscal 2004 and beyond.

23


The Sign Making and Specialty Graphics segment profit increased $0.6 million in the first quarter of fiscal 2004 compared to the same period last year. The increase reflected higher year-over-year sales of aftermarket products, cost savings resulting from last year's third quarter restructuring, lower current year incentive compensation expense, and the favorable impact of foreign currency translation, which contributed approximately $0.7 million of the segment profit growth. The lower operating results in France previously discussed and higher pension expense somewhat offset these increases.

Apparel and Flexible Materials segment revenues decreased $1.1 million (2.8 percent) in the first quarter of fiscal 2004 compared to the same period last year reflecting a decrease in U.S. regions and increases in European and Rest of World regions. The favorable impact of foreign currency translation contributed approximately $1.9 million to the revenue increase reflecting primarily the strengthening of the Euro in relation to the U.S. dollar. Holding foreign currency translation at last year's first quarter rates, revenue increased only in Rest of World markets. Segment revenue was affected by low apparel and automotive customer spending at the retail level, customer consolidation, and the continued production migration from North American and Western European markets to emerging Eastern European and Far East markets. This segment did benefit from higher revenue in certain of these emerging markets, albeit at lower gross margins as these sales are often made through thi rd party distribution. Aftermarket revenues were higher in the first quarter of fiscal 2004 compared to the same period last year, which helped offset lower capital equipment and software sales.

The Apparel and Flexible Materials segment profit decreased $1.0 million in the first quarter of fiscal 2004 compared to the same period last year. The decrease reflected pricing pressures, the effects of the lower revenues, year-over-year sales mix favoring lower margin equipment products over higher margin software products, and higher pension expense. Competitive price discounting was required in the first quarter of fiscal 2004 in countries where apparel and automotive production is migrating, particularly in countries such as Pakistan, India, and Turkey.  Additionally, gross margins are typically lower in these countries because sales are often made through independent distributors and agents as opposed to the segment's internal sales force. Cost savings resulting from last year's third quarter restructuring, lower current year incentive compensation expense, and the favorable impact of foreign currency translation, which contributed to approximately $0.5 million to segme nt profit, partially offset the revenue decreases.

Ophthalmic Lens Processing segment revenues decreased $2.3 million (11.0 percent) in the first quarter of fiscal 2004 compared to the same period last year reflecting decreases in U.S. and European regions and a slight increase in Rest of World regions. Foreign currency translation had an insignificant impact on segment operating results in both periods. Segment revenues were affected by continued low levels of eyewear prescription volumes, lower than historical capital spending by retail and discount eyewear chains, customer consolidations, and the absence of approximately $1.9 million of automated lens processing equipment sales to large U.S. retail and discount eyewear chains in the first quarter of fiscal 2004 that occurred in last year's first quarter.  Aftermarket supplies revenues were approximately the same in both of the first quarter fiscal periods and provided some offset to the lower capital equipment revenues.

24


The Ophthalmic Lens Processing segment profit decreased $1.1 million in the first quarter of fiscal 2004 compared to the same period last year. The decrease reflected the lower volume of business and the resulting cost of employee separations. Lower incentive compensation expense and strict discretionary spending in the first quarter of 2004 partially offset these decreases.

LIQUIDITY AND CAPITAL RESOURCES

We assess our liquidity in terms of our ability to generate cash to fund our operating and investing activities. Significant factors affecting the management of liquidity are: cash flows generated from operating activities, capital expenditures, adequacy of available bank lines of credit, and the ability to attract long-term capital with satisfactory terms. Our short-term liquidity at July 31, 2003 was adequate for our requirements and we expect that available cash and our existing credit facilities will be sufficient to meet normal operating requirements over the next twelve months. However, there is no assurance that we will not need to raise additional equity or debt financing within this time frame. Further, the impact on our cash flow could be significant if we were unable to meet required covenants in our credit facilities. This might be caused by further deterioration in global economic conditions that would affect demand for our products; additional charges that may be required because of weak economic conditions, market changes, and delayed product introductions; and our ability to complete our ongoing efforts to improve operational efficiencies. Accordingly, additional financing may not be available on favorable terms, or at all, and may be dilutive to then-current shareholders.


Dollars in thousands

 

July 31,
   2003   

April 30,
   2003   

       

Cash and cash equivalents

 

$   10,777

$   20,697

Total debt

 

89,673

85,807

Net debt (total debt less cash)

 

78,896

65,110

Shareholders' equity

 

96,218

94,463

Total capitalization (net debt plus equity)

 

175,114

159,573

Net debt to total capitalization

 

45.1%

40.8%

Cash Flows. Cash used by operating activities increased $13.2 million in the first quarter of 2004 compared to the same period in 2003 due primarily to the lower operating earnings and a reduction in accounts payable and accrued liabilities. Lower accounts payable and accrued liabilities were primarily the result of higher incentive compensation payments (based on last year's operating results) and lower current year incentive compensation accruals (based on this year's operating results), but also related to timing of payments.

Cash provided by investing activities decreased $8.3 million in the first quarter of 2004 compared to the same period in 2003 due primarily to the absence of proceeds from assets sales of $2.5 million and the sale of a discontinued operation of $6.6 million recorded in the first quarter of 2003. Capital expenditures in the first quarter of fiscal 2004 were $0.5 million and are anticipated to be approximately $7.0 million for the full fiscal year. Funding for these capital expenditures is expected to come from our senior revolving credit facility.

25


Cash used for financing activities decreased $5.6 million in the first quarter of 2004 compared to the same period in 2003 due primarily to higher current year credit facility borrowings, which was substantially offset by payments of debt issuance costs related to our new credit facilities.

Financial Condition. The ratio of current assets to current liabilities was 1.6 to 1 at July 31, 2003 and at April 30, 2003. Net working capital at July 31, 2003 was $61.3 million, a decrease of $2.5 million from the beginning of the fiscal year. The decrease in working capital was primarily due to lower cash balances caused by lower operating income, which was partially offset by the reduction in accounts payable and accrued expenses during the first quarter of fiscal 2004.

Credit Facilities. On May 9, 2003, we entered into a four-year $110.0 million senior credit facility arranged by Fleet Securities, Inc. The financing consisted of a $45.0 million asset-based, multi-currency revolving credit facility (the "Revolver") led by Fleet Capital Corporation, and two term loan facilities, each in the amount of $32.5 million (the "Term A Loan" and "Term B Loan" and collectively, the "Term Loans"), led by Ableco Finance LLC, a fund affiliated with Cerberus Capital Management, L.P. (the Revolver and Term Loans being collectively referred to as the "Credit Facilities"). The terms of the agreements memorializing the Credit Facilities enabled us to meet our primary objectives by refinancing our debt without shareholder dilution and prepayment penalties after the first year and to provide us with the liquidity and flexibility needed to support our ongoing turnaround efforts.

The lenders under these arrangements have been granted security interests in selected assets of the Company and its subsidiaries including certain real estate and leasehold interests in the U.S. and elsewhere; inventory and accounts receivable in the U.S., Canada, U.K., Germany, and the Netherlands; intangible assets; intellectual property; and other assets.

We are required to maintain certain financial covenants as defined in the Revolver agreement including certain fixed charge coverage ratios, total liabilities to tangible capital base ratios, and consolidated EBITDA (as defined) as well as limitations on capital expenditures. The agreement also includes limitations on additional indebtedness and liens, contingent liabilities, asset sales and dividends, investments and hedging activities, transactions with affiliates, legal entity changes, and other customary covenants and representations.

Additionally, we are required to maintain certain financial covenants as defined in the Term Loan agreements including maintenance of certain leverage ratios, fixed charge coverage ratios, and consolidated EBITDA (as defined) levels, as well as limitations on capital expenditures. The agreement also includes limitations on additional indebtedness and liens, contingent liabilities, asset sales, dividends, issuance of capital stock, investments and hedging activities, transactions with affiliates, and other customary covenants and representations. The Term Loans do not have scheduled principal repayments until the maturity (i.e., at the end of four years).

26


We were in compliance with the financial covenants under our Credit Facilities at July 31, 2003.  However, we may not be able to satisfy these covenants in the future because our financial performance may be impacted by various economic, financial, and industry factors. Noncompliance with these covenants would constitute an event of default, allowing the lenders to accelerate the repayment of any borrowings outstanding under the Credit Facilities. We believe we would be able to successfully negotiate amended covenants or obtain waivers if an event of default were imminent; however, we might be required to provide additional collateral to the lenders or make other financial concessions, including those that may be dilutive to existing shareholders. Furthermore, our operating results and financial condition might be adversely affected if we were unable to successfully negotiate amended covenants or obtain waivers on acceptable terms.

OBLIGATIONS, COMMITMENTS, AND CONTINGENCIES

There were no material changes to our cash obligations or commercial commitments from those disclosed in its Form 10-K filed on July 29, 2003.

CRITICAL ACCOUNTING POLICIES

The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported. We described the critical accounting policies that require management's most difficult, subjective, or complex judgments in its Form 10-K filed on July 29, 2003. This disclosure continues to be relevant to the current year.

NEW ACCOUNTING PRONOUNCEMENTS

In November 2002, the EITF reached a consensus on Issue No. 00-21, "Revenue Arrangements with Multiple Deliverables." EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services, and/or rights to use assets. The provisions of EITF Issue No. 00-21 will apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. We are currently evaluating the effect that the adoption of EITF Issue No. 00-21 will have on our results of operations and financial condition.

In January 2003, the FASB issued Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51." FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. We are currently evaluating the effect that the adoption of FIN 46 will have on our results of operations and financial condition, if any.

In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." SFAS No. 149 amends and clarifies SFAS No. 133 including the expansion and clarification of scope exceptions, clarifications to the character-based definitions of a derivative instrument, an embedded derivative, and net settlement contracts, and requires additional disclosure in the statements of cash flows associated with a derivative having a significant financing element. SFAS No. 149 is generally effective for contracts entered into or modified after June 30, 2003. We do not believe that the adoption of SFAS No. 149 will have an impact on our financial position or results of operations.

27


In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity."  SFAS No. 150 establishes standards for measuring and classifying certain financial instruments with characteristics of both liabilities and equity. Financial instruments that are within the scope of SFAS No. 150 must be classified as a liability (or asset). SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003 and otherwise is effective on August 1, 2003 for the Company. We do not believe that the adoption of SFAS No. 150 will materially impact our financial position or results of operations.

FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q contains statements which, to the extent they are not statements of historical or present fact, constitute "forward-looking statements" under the securities laws. From time to time, oral or written forward-looking statements may also be included in other materials we release to the public. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. Forward-looking statements within this quarterly report can be identified by the use of words such as "believe," "expects," or "expected to," "intends," "foresee," "may," or "should," "plans," "anticipate," and other words of similar meaning in connection with a discussion of future operating or financial performance. Forward-looking statements contained in this quarterly report relate to, among other things:

28


All forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Certain risk factors that could cause actual results to differ from expectations are set forth in this quarterly report on Form 10-Q. We cannot assure you that its results of operations or financial condition will not be adversely affected by one or more of these factors.

For additional information identifying factors that may cause actual results to vary materially from those stated in the forward-looking statements, see our reports on Forms 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission from time to time. Form 10-K for fiscal 2003 filed on July 29, 2003 includes important information as to risk factors in the "Business" section under the heading "Risk Factors."

29


ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES
                    ABOUT MARKET RISK

No material changes have occurred in the quantitative and qualitative market risk disclosures for the Company during the first three months of fiscal 2004.

For discussion of the Company's exposure to market risk, refer to Item 7a, Quantitative and Qualitative Disclosures about Market Risk, presented in the Company's annual report on Form 10-K for the year ended April 30, 2003, filed with the SEC on July 29, 2003.

ITEM 4.     CONTROLS AND PROCEDURES

Rules adopted by the SEC to implement the provisions of Section 302 of the Sarbanes-Oxley Act require the Chief Executive Officer (CEO) and Chief Financial Officer (CFO) of the Company, in connection with the Company's periodic reports filed with the SEC, to certify, among other things:

Disclosure controls and procedures refer to controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures as of the end of the fiscal quarter covered by this report was carried out by the Company under the supervision and with the participation of the Company's management, including the CEO and CFO.  Based on that evaluation, the CEO and CFO concluded that the Company's disclosure controls and procedures have been designed and are being operated in a manner that provides reasonable assurance that the information required to be disclosed by the Company in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms.

A control system, no matter how well designed and operated, cannot provide absolute assurance that the objective of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

30


Subsequent to the date of the most recent evaluation of the Company's internal controls, there were no significant changes in the Company's internal controls or in other factors that could significantly affect the internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses.   

A separate organization of the Company, internally referred to as Gerber Scientific Operations (GSO), was created as a part of the shared services initiative. During the first quarter of fiscal 2004, certain disclosure controls surrounding the Company's process of recording, processing, summarizing and reporting financial and non-financial information have changed to enable the Company to combine certain accounting functions of its Gerber Technology and Gerber Scientific Products subsidiaries. The Company is evaluating the revised accounting procedures as they evolve to ensure that disclosure controls remain in place. The Company believes that the appropriate internal controls were in place subsequent to the formation of GSO, and will continue to evaluate the controls in place throughout fiscal 2004 and as changes are implemented to existing accounting procedures.

31


PART II -- OTHER INFORMATION

ITEM 2.     CHANGES IN SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

Non-employee Directors Stock Grant and Stock Plans

The Company issued or committed to issue shares of its common stock to non-employee members of the Company's Board of Directors as follows:

  1. On June 30, 2003, we committed to issue 7,508 shares of our common stock under the Company's Non-Employee Director's Stock Grant Plan (the "Director's Plan").

These grants were made as partial compensation for the recipients' services as directors in accordance with the terms of the Director's Plan. The issuance of these securities was exempt from registration under Section 4(2) of the Securities Act of 1933 (the "Securities Act"), as transactions by an issuer not involving any public offering.

32


ITEM 6.     EXHIBITS AND REPORTS ON FORM 8-K

(a)    Exhibits

See the Exhibit Index following the Signature of this quarterly report.

(b)    Reports on Form 8-K

Two Form 8-K's were filed in the first quarter of fiscal year 2004. The first 8-K, dated May 12, 2003, contained a press release announcing that, on May 9, 2003, the Company closed on a four-year $110.0 million senior credit facility arranged by Fleet Securities, Inc. The second 8-K, dated May 29, 2003, contained a press release announcing its fiscal 2003 year and fourth quarter results.

 

33


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

GERBER SCIENTIFIC, INC.

(Registrant)

     
     

Date: September 11, 2003

 

By:

/s/ Shawn M. Harrington

     

Shawn M. Harrington

     

Executive Vice President

34


EXHIBIT INDEX

Exhibit
Index
Number

   



       

10.1

 

2000-2004 Executive Annual Incentive Bonus Plan, as submitted to shareholders for approval.

 
       

10.2

  Ableco Finance LLC First Amendment to Financing Agreement  
       

10.3

  Fleet Capital Corporation First Amendment Agreement  
       

   15

 

Letter regarding unaudited interim financial information.

 
       

31.1

 

Rule 13a-14(a)/15d-14(a) Certification of CEO.

 
       

31.2

 

Rule 13a-14(a)/15d-14(a) Certification of CFO.

 
       

32.1

 

Section 1350 Certification of CEO.

 
       

32.2

 

Section 1350 Certification of CFO.

 
       

   99

 

Supplemental Segment Information.

 
       
       

35